Clinical Trial

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The primary objective of the study was to evaluate the safety and tolerability of A-319 in patients with active rheumatoid arthritis.
Trial Details
NCT Number NCT07347860
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators: ITabMed Co., Ltd.
Conditions Rheumatoid Arthritis (RA)
Enrollment 12 participants
Start Date 2026-01-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-16